Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone and alcohol-related memory in risky drinking
NCT04896489Phase 1Completed
- Sponsor
- Yale University
- Start
- May 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in alcohol use disorder (AUD) comparing Hydrocortisone Arm with Placebo Arm (2 arms). Primary endpoints: Changes in fMRI signal at 1 hour, Item memory at 90 months and 2 more. Started May 2021; status: completed.
02
Drugs
hydrocortisone
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT04896489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04896489.